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A B S T R A C T
A study was designed to find out whether MMPI-2 validity scales and indexes differentiate between true 
fibromyalgia sufferers, patients with chronic organic pain and normal people, as well as whether they are 
correctly classified. 105 subjects participated in the study, 27 diagnosed with fibromyalgia and 44 with 
chronic organic pain and 34 were healthy people, who answered the MMPI-2 following standard 
instructions. The results showed that fibromyalgia patients scored higher than the control group in the F, 
Fb, F-K, Fp, Ds, and FBS scales and indexes and that patients with chronic organic pain scored higher in the 
Ds and FBS scales than the control group. The case study revealed that the F, Fb, F-K, Fp, Ds, and FBS scales 
and indexes over-diagnose malingering in patients with fibromyalgia, both in comparison with the clinical 
population and with the normative group. Likewise, patients with chronic organic pain were over-
diagnosed as malingerers by all the scales and indexes in comparison with the normative population and 
by the Fp and FBS scales in comparison with the clinical population. In addition, it was found that at least 
one of the scales for measuring defensiveness –L, Wsd and Mp– classified 79.5% of the truly ill patients as 
faking good. The implications for clinical and forensic practice are discussed, as well as for the definition of 
decision criteria and the (re)classification as true negatives of genuine cases classified as malingerers by 
the malingering measuring scales and indexes.
© 2013 Colegio Oficial de Psicólogos de Madrid. All rights reserved. 
¿Son clasificados correctamente los pacientes con dolor crónico y fibromialgia 
por las escalas e índices de validez del MMPI-2?
R E S U M E N
Se diseñó un estudio con el objetivo de conocer si escalas e índices de validez del MMPI-2 diferencian entre 
verdaderos enfermos de fibromialgia, pacientes con dolor crónico de etiología orgánica y personas norma-
les, así como si los clasifican correctamente. Participaron en el estudio 105 sujetos, 27 diagnosticados de 
fibromialgia, 44 de dolor crónico con etiología orgánica y 34 sanos, que respondieron al MMPI-2 bajo las 
instrucciones estándar. Los resultados mostraron que los pacientes de fibromialgia puntuaban más alto en 
las escalas e índices F, Fb, F-K, Fp, Ds y FBS que el grupo control y los pacientes de dolor crónico con etiolo-
gía orgánica en las escalas Ds y FBS. El estudio de casos evidenció que las escalas e índices F, Fb, F-K, Fp, Ds 
y FBS sobrediagnostican simulación en los pacientes con fibromialgia, tanto en comparación con la pobla-
ción clínica como con la normativa. Asimismo, los pacientes con dolor crónico con etiología orgánica fue-
ron sobrediagnosticados como simuladores por todas las escalas e índices en comparación con la población 
normativa y por las escalas Fp y FBS en comparación con la población clínica. Además hallamos que al me-
nos una de las escalas de medida de defensividad –L, Wsd y Mp– clasificaba como disimuladores al 79.5% 
de los verdaderos enfermos. Se discuten las implicaciones para la práctica clínica y forense, así como para 
la definición de criterios de decisión y la (re)clasificación como verdaderos negativos de aquellos casos ge-
nuinos clasificados como simuladores por las escalas e índices de medida de la simulación.
© 2013 Colegio Oficial de Psicólogos de Madrid. Todos los derechos reservados.
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The International Association for the Study of Pain (Merskey & 
Bogduk, 2010) defines pain as an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or 
described in terms of such damage, specifying that it is chronic if it 
persists beyond the normal tissue healing time (usually 3 months). 
The time that needs to elapse for pain to be specified as chronic 
varies from one study to another depending on the type of population, 
research methodology, etc., oscillating between 3 and 6 months, and 
some authors have also added criteria such as intensity and frequency 
for pain to be specified as chronic (Johannes, Le, Zhou, Johnston, & 
Dworkin, 2010). As a result of all this and of potential cultural 
differences in pain management, prevalence rates are highly 
fluctuating. Thus, Breivik, Collet, Ventafridda, Cohen, and Gallacher 
(2006) found a prevalence of 19% among European adults, whereas 
Johannes et al. (2010) found 30.7% in North American adults. Either 
way, not only does chronic pain constitute one of the greatest health 
problems but it is also the most important (Breivik et al., 2006) and 
the most common cause of disability in the middle-aged population 
(Scascighini, Toma, Dober-Spielmann, & Sprott, 2008). It also carries 
high socio-medical costs (Gaskin & Richard, 2012; Van Leeuwen, 
Blyth, March, Nicholas, & Cousins, 2006). Chronic pain is comorbid 
with emotional suffering, psychopathology, and with alterations in 
relational, social, and professional activity (Gatchel, 2004; Ilgen, 
Zivin, McCammon, & Valenstein, 2008; Tecic, Lefering, Althaus, 
Rangger, & Neugebauer, 2013; Tsang et al., 2008).
Generally, chronic pain occurs with organically caused pathologies, 
but this is not always so. Fibromyalgia, which was recognised as a 
disease by the World Health Organization (1992) with its 
incorporation in ICD-10, was characterized by the absence of a clear 
organic etiology, but with the presence of chronic pain (Bellato et al., 
2012). Previously the American College of Rheumatology (ACR) had 
defined the diagnostic criteria: pressure pain in at least 11 out of 18 
tender points and the presence of widespread pain (Wolfe et al., 
1990). Faced with the difficulties in applying and assessing these 
criteria whereby the diagnosis depended practically exclusively on 
patients’ self-reports, in 2010 the ACR itself introduced the 
Widespread Pain Index (WPI), a measure of the number of areas in 
which the patient complains of pain, and severity scales for fatigue, 
cognitive symptoms, unrefreshing sleep, and some somatic 
symptoms, which were to be comprehensively integrated in the 
Symptom Severity scale (SS). Hence, by combining the WPI and the 
SS a new definition of fibromyalgia is formulated in the following 
terms: (WPI ≥ 7 and SS ≥ 5) or (WPI 3-6 and SS ≥ 9). Either way, it is 
a very complicated diagnosis, which opens the door to misdiagnoses 
(Wierwille, 2012). The prevalence of fibromyalgia is between 2 and 
3% (Branco et al., 2010; Wolfe, Ross, Anderson, Rusell, & Hebert, 
1995) and also entails high socio-medical costs (Winkelmann et al., 
2011).
The perception of pain constitutes a subjective experience which 
makes its objective measurement difficult, while at the same time it 
is a fertile ground for claiming compensation (e.g., damages, 
disability pensions). In assessing compensation, which falls squarely 
in the field of forensic evaluation, it is always necessary to make a 
differential diagnosis of malingering (American Psychiatric 
Association, 2000), which Greve, Ord, Bianchini, and Curtis (2009) 
calculated at between 20 and 50%.
The comorbidity of chronic pain with emotional suffering (that is, 
psychological damage), psychopathology, with alterations in 
relational, social and professional activity entails the fact that, in 
addition to medical tests and diagnosis, it also requires a psychological 
assessment of these comorbid pathologies and the differential 
diagnosis of malingering. Since the perception of pain is purely 
subjective, physical tests play a limited role in the differential 
assessment of malingering; therefore psychological assessment is a 
good, even indispensable, complement for differential diagnosis. 
Although instruments have been developed for this purpose, some of 
them exclusively, such as TOMM, MMPI is the benchmark instrument 
in psychological assessment and the assessment of malingering 
(Greene, 2011; Rogers, 2008; Rogers, Sewell, Martin, & Vitacco, 
2003), including chronic pain (Aguerrevere, Greve, Bianchini, & 
Meyers, 2008; Greve et al., 2009; Huss, 2009; Meyers, Millis, & 
Volkert, 2002).
Therefore we undertook, in the framework of psychological 
assessment associated to chronic pain and fibromyalgia, a field study 
in order to find out whether MMPI-2 validity scales and indexes –the 
benchmark instrument in forensic psychological assessment– 
differentiate between genuine patients with chronic organic pain, 
patients with chronic fibromyalgia, and a control group. Likewise, we 
ascertain whether genuine patients are correctly classified as having 
chronic pain with an underlying organic etiology and fibromyalgia. 
Finally, we seek the forensic gold standard definition, as well as new 
criteria which will enable the correct identification of genuine 
patients.
Method
Participants
105 subjects participated in the study divided into 3 groups: 
patients diagnosed with fibromyalgia, patients diagnosed with 
chronic pain, and healthy subjects. The fibromyalgia group was made 
up of 27 participants, 24 women (88.9%) and 3 men (11.1%), with a 
mean age of 46.48 years (95% CI: 42.53-50.43). The chronic pain 
group was made up of 44 patients, 38 women (86.4%) and 6 men 
(13.6%) with a mean age of 45.82 (95% CI: 42.97-52.43), and the 
group of healthy individuals (hereinafter, control group) was made 
up of 34 healthy people, 31 women (91.2%) and 3 men (8.8%), with a 
mean age of 48.38 (95% CI: 44.33-52.43).
Measurement instrument
The Spanish adaptation of the MMPI-2 (Hathaway & Mckinley, 
1999) was adopted as the measuring instrument. For the differential 
diagnosis of malingering –a requirement in a forensic evaluation 
context (American Psychiatric Association, 2000)– all the necessary 
scales and indexes were taken in order to follow the model by Arce, 
Fariña, Carballal, and Novo (2006, 2009) of research and knowledge 
transfer into forensic practice: measure of cooperation with the 
evaluation, measure of consistency, and measure of negative (i.e., 
which invalidate the protocol) and positive (i.e., which validate the 
protocol) criteria for the evaluation of the validity of the protocols. 
Negative criteria are those that invalidate the protocol due to 
malingering and positive criteria are the ones that validate it. The 
measure of collaboration with the evaluation was assessed with the 
Cannot Say scale (?) and the consistency of the responses by TRIN 
(acquiescence) and VRIN and F-Fb (random responses). For the study 
of negative criteria regarding malingering we took the scales and 
indexes that the literature has systematically related to predictors of 
this: Infrequency scale (F), Back Infrequency scale (Fb), F minus K 
index (F-K), Infrequency-Psychopathology scale (Fp), Gough 
Dissimulation scale (Ds), and Fake Bad scale (FBS) (Friedman, Lewak, 
Nichols, & Webb, 2001; Graham, 2006; Greene, 2011; Rogers, Sewell, 
Martin, & Vitacco, 2003). Ds scale was preferred to the abbreviated 
version Ds-r, because of its large effect size (d = 1.62 vs. 1.49), 
sophisticated strategy and minimal false positives (Rogers et al., 
2003). As measures of potential positive validity criteria we took the 
scales and indexes of relevance for the study of defensiveness, as 
these can be effective in identifying true clinical cases since they are 
not related to malingering and are not detected in malingerer 
protocols but are found in assessments of psychological damage in 
genuine victims of crime (Arce et al., 2006, 2009): Lie scale (L), 
Correction scale (K), F minus K index (F-K), Positive Malingering 
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scale (Mp), Wiggins Social Desirability scale (Wsd), Edwards Social 
Desirability scale (Esd), Other Deception scale (Odecep) and 
Superlative scale (S) (Baer & Miller, 2002; Friedman et al., 2001; 
Graham, 2006, Greene, 2011). Although Odecep was created as an 
updated version of the Mp, the results of this study showed a 
significant incremental validity for chronic pain case classification, 
χ2(1) = 6.25, p < .05, for Mp in relation to Odecep. Thus, both scales 
were considered for the study.
Procedure and design
The participants making up the groups of Fibromyalgia and 
Chronic Pain (non-fibromyalgia) were patients diagnosed as such by 
the health services in Mallorca (Spain), were under treatment, and 
had a clinical record (in all cases there was a record of specification 
> 6 months, high frequency, and intensity). The patients diagnosed 
with chronic pain had a clinical record of a non-inflammatory 
objectified pathology of the musculoskeletal system that supported 
organic etiology. The diagnosis of fibromyalgia was contrasted with 
rheumatologists who were blind to the original diagnosis, according 
to classification criteria for the disease (Wolfe et al., 1990; Wolfe et 
al., 2010). We included only the cases in which, as well as coinciding 
in the diagnosis, there was a total coincidence in diagnostic criteria. 
Patients with prior diagnoses of mental illness and those waiting to 
receive some possible secondary gain (disability pension, economic 
compensation, etc.) were rejected for the study.
Once the patients had been selected and the cross-diagnosis of 
fibromyalgia had been verified, the Spanish adaptation of MMPI-2 
(Hathaway & McKinley, 1999) was applied in standard response 
conditions by assessors who were unaware of the patient’s diagnosis. 
Patients gave their written consent to the evaluation; afterwards 
they were given a debriefing and an interview to learn their degree 
of task engagement and motivation (recall and comprehension of 
instructions) and to ensure participants had understood and completed 
the task correctly (Rogers, 2008). The resulting clinical profile in the 
MMPI-2 of patients was reviewed by the doctors of reference who 
confirmed that this was compatible with their records and diagnostic 
impression.
A design was planned to compare the measurements of the 
clinical patients diagnosed with fibromyalgia and chronic pain with 
a control group in the MMPI-2 validity measures. The control group, 
with no pain or chronic pathology, was randomly selected to fit the 
socio-demographic characteristics of the patients with chronic pain 
and fibromyalgia out of the people who attended Primary Care 
Services with mild health problems. The groups were matched by 
taking into account the socio-demographic characteristics (e.g., 
gender, age, job situation) of fibromyalgia patients (smallest group) 
and the clinical record (e.g., time since diagnosis, confidence of the 
diagnosing physician). A case study was also planned with the 
normative and clinical populations as contrast values.
Data analysis
Firstly, the difference in means between groups was studied; 
then, the assumptions of the analysis of variance of normality and 
homogeneity of variance of the variables were verified in order to 
define which statistical test to use. Table 1 presents the results of the 
test for normality (Shapiro-Wilk’s test) and homogeneity of variance 
(Levene’s test) of the measurement variables of the study. The lack of 
homogeneity of variance and/or normality in most of the variables to 
be studied, as well as our interest in comparing means, recommended 
the general use of a non-parametric test, the Kruskal-Wallis test, 
with Dunn-Bonferroni post hoc tests (Palmer, 2011).
The case study was addressed using classification rates, a test of 
the proportion observed with the expected observation (chronic 
pain and fibromyalgia groups vs. control group) using the Z statistic, 
and the effect size using the Odds Ratio (OR). As for the interpretation 
of the ORs in Cohen’s effect size categories, these were converted, 
with the formula of Chinn (2000), to Cohen’s d, which allows an 
interpretation in terms of z-scores.
Results
There are three steps that Arce et al. (2006, 2009) relate in the 
model of research and knowledge transfer into forensic practice in 
the study of MMPI protocols in forensic evaluation. The first step is 
the analysis of cooperation with the assessment, in such a way that 
if a lack of cooperation were to be observed, the protocol should be 
invalidated. In this respect, the results of the mean difference test in 
the Cannot Say scale (?) –which measures collaboration with the 
assessment through the number of items left unanswered or double 
answered– reveal that both patients with chronic pain and 
fibromyalgia and the control group collaborate with the assessment 
to the same extent.
The second step is the assessment of the consistency of responses 
both in terms of (non)acquiescence (TRIN) and random responses 
(VRIN, |F-Fb|). The results, which can be seen in Table 2, reveal 
differences between populations in acquiescence (TRIN), which the 
Dunn-Bonferroni post hoc tests pinpointed as patients diagnosed 
with chronic pain showing a more acquiescent pattern of responses 
than the control group, whereby it can be concluded that the 
responses in all the conditions are not acquiescent, even though the 
means of the three groups fall within the region of normality (5 < 
raw score < 13) in TRIN. Meanwhile, in VRIN and |F-Fb| the three 
groups have equal means that are within the region of normality. 
As a result, it can be concluded that, on the whole, the protocols of 
patients diagnosed with chronic pain and fibromyalgia are 
consistent.
The third step, which is performed if lack of cooperation and 
inconsistency have been eliminated in the responses, is the analysis 
of the validity of the protocol. This third step is, in turn, divided, 
depending on the availability of the control scales, into the original 
validity control scales and indexes –that is, those that were originally 
formulated in the MMPI and which are available in the commercial 
version and, as such, are the ones used by forensic psychologist in 
their everyday practice– and additional validity control scales which 
are used scientifically but are not in the commercial version of 
MMPI-2 and, therefore, are not used by forensic psychologists in 
their everyday practice. In the original validity scales, the results (see 
Table 2) showed statistically significant differences between samples 
in the F and Fb scales, and the F-K index. The Dunn-Bonferroni post 
hoc tests established that the patients diagnosed with fibromyalgia 
obtained significantly greater scores than the control group in the F 
and Fb scales and in the F-K index.
As regards the additional validity scales, the results unveiled 
differences in the Fp, Ds, FBS, and Esd scales mediated by the 
population factor (see Table 2). The Dunn-Bonferroni post hoc tests 
revealed that the patients diagnosed with chronic pain obtained 
significantly higher scores in the Ds and FBS scales than the control 
group and that the patients diagnosed with fibromyalgia obtained 
significantly higher scores in the Fp, Ds, and FBS scales and lower 
scores for Esd than the control group. Namely, the Ds and FBS scales 
Table 1
Summary of the Tests for Normality and Homogeneity of Variance of the 
Measurement Variables of the Study in the Protocols of Participants
Normality
Yes No
Variance 
Homogeneity
Yes K, S, Wsd, VRIN, L, TRIN
No PM, Esd, Odecep F, Fb, F-K, P, Ds, FBS
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report a tendency towards malingering among patients diagnosed 
with chronic pain, just like the Fp, Ds, and FBS scales did among 
patients diagnosed with fibromyalgia.
Mean comparison studies are extremely useful in science and 
research but are insufficient for knowledge transfer to professional 
practice, which requires N = 1 designs. This has led the American 
Psychiatric Association (2000) to recommend additional analyses to 
mean comparison and, within the forensic field, Arce et al. (2006, 
2009) urged in their model of evaluation and knowledge transfer, in 
order to be able to transfer knowledge into forensic practice, mean 
comparison analyses to be conducted along with case studies and 
the derivation of forensic decision criteria. Therefore, we will 
immediately proceed with the case study and with the identification 
of forensic decision criteria.
Going back to the aforementioned steps, as regards cooperation 
with the assessment, the case study reveals that all the people 
assessed cooperated with the assessment, as none exceeded the cut-
off point for suspected lack of cooperation with the assessment (raw 
score > 10; Graham, 2006). The analysis of the cases and items 
showed that patients with fibromyalgia answered all the items and 
that the only item left unanswered detected in patients with chronic 
pain is not part of the validity scales.
The inconsistency study shows (see Table 3) significantly higher 
rates (.02 was taken as the test criterion as these cut-off scores are 
calculated approximately on the 98th percentile) of cases classified 
by the inconsistency measures such as in TRIN and VRIN among 
patients diagnosed with chronic pain and in TRIN, VRIN, and |F-Fb|in 
the population of patients diagnosed with fibromyalgia. The ORs 
(observed/expected prevalence) exhibit a likelihood of classification 
of random responses, VRIN, which is 3.4 times greater for chronic 
pain patients than for the control group and 6.8 times greater for 
acquiescence, TRIN. Likewise, the ORs also indicate a likelihood of 
classification of acquiescence that is 6.8 times higher for fibromyalgia 
patients than for the control group and 5.6 times greater likelihood 
of random responses by TRIN and 14.8 by |F-Fb|.
Since the participants’ responses were obtained in a non-forensic 
context and under standard instructions –that is, they are presumably 
honest answers– the classification of the protocol validity indicators 
as typical of malingering is a false positive. By comparing the 
observed proportion of protocols classified as fake bad (see Table 4) 
with the expected prevalence, as we were dealing with clinical cases, 
in the clinical population (the criteria taken from Caldwell are for the 
98th percentile of the clinical population, in which the expected 
likelihood of wrong classification of real cases as fake bad is ≤ 2%, 
whereby the test value is .02) it was found that all the original and 
additional malingering indicators classified the protocols of patients 
diagnosed with fibromyalgia as invalid (false positives) beyond what 
was expected for clinical population, with an over-diagnosis of 
invalidity which oscillates between 11.1 times more than expected 
for the clinical population in the Ds scale and 20.4 in the FBS, in so 
far as the patients diagnosed with chronic pain would be over-
diagnosed by the Fp and FBS scales (2 out of 6 indicators), with over-
diagnosis of invalidity rates 4.6 times greater than for the clinical 
population for the Fp scales, and 8 times greater for FBS. Nevertheless, 
as in forensic practice the object of study are N = 1 designs, these 
results do not allow us to define a forensic decision criterion. At this 
point, Arce et al. (2006, 2009) urge, in their model of research and 
knowledge transfer, the definition of a forensic decision criterion, 
that is, typical of N = 1 designs, by studying the frequency of 
indicators per case. After implementing this, we found in 4 cases of 
fibromyalgia up to 5 indicators of malingering and in 1 case of 
chronic pain 5 indicators too, which enabled us to identify as true 
positives (fake good cases) the protocols in which the presence of 5 
or more invalidating criteria is detected.
However, forensic evaluation is not considered a clinical context, 
wherefore the contrast population would not necessarily be the 
clinical one, but rather the normative one. The results (see Table 5) 
Table 2
Evidence of the Mean Difference Tests in the MMPI-2 Validity Indicators for the 
Population Factor (Fibromyalgia Patients, Chronic Pain Patients and Control Group)
Indicator  MCG   MCP   MF  χ2(a) p
Item omissions  0.03  0.02  0.00  0.74 .689
Consistency
VRIN  8.12  8.52  8.85  0.65 .722
TRIN  9.35 10.41  9.96  6.09 .048
|F-Fb|  3.32  4.00  7.07  4.54 .103
Original validity scales
F  6.94  9.55 21.67 29.11 .001
Fb  4.09  6.09 15.78 31.23 .001
L  6.97  6.84  7.15  0.10 .950
K 1 5.00 13.14 13.29  4.75 .093
F-K index - 8.06 -3.59  8.37 26.66 .001
Additional validity scales
Fp  2.15  3.16  8.37 14.09 .001
Ds 11.29 16.45 26.33 34.65 .001
FBS 17.03 20.93 24.56 17.56 .001
S 24.53 22.75 22.48  2.29 .318
Wsd 15.41 16.23 15.22  3.19 .203
Odecep 15.12 16.00 15.67  1.57 .456
PM 11.29 12.00 12.30  1.19 .552
Esd 24.91 21.66 17.63 27.90 .001
Note. df(2); (a)Kruskal-Wallis test.
Table 3
Classification Rate of the Inconsistency Indicators
Chronic pain Fibromyalgia
Indicator Cut-off score f(p) Z OR f(p)    Z  OR
TRIN ≥ r13a 6(.136) 5.50** 6.8 3(.111)  3.38**  5.6
VRIN ≥ r13a 3(.068) 2.27* 3.4 3(.111)  3.38**  5.6
|F-Fb| ≥ r10b 2(.045) 1.18 ---- 8(.296) 10.26** 14.8
Note. acut-off score from Butcher, Dahlstrom, Graham, Tellegen, and Kaemmer 
(1989); bcut-off score from Greene (2008) for clinical settings; dashes indicate that 
ORs were not computed because the observed prevalence of cases was not 
statistically significant; +raw scores in TRIN ≤ 5 are also suggestive of inconsistency 
(response in the direction of false), but no contingency was recorded under this 
circumstance; *p < .05, **p < .001.
Table 4
Classification Rate of Malingering Indicators with Clinical Cut-off Scores
Chronic pain Fibromyalgia
Indicator Cut-off scorea f(p) Z OR f(p) Z OR
F scale≥ ≥ r25 1(.023) 0.14 ---- 8(.296) 10.26** 14.8
F-K index ≥ r17 1(.023) 0.14 ---- 8(.296) 10.26** 14.8
Fb scale ≥ r21    0(0) ---- ---- 8(.296) 10.26** 14.8
Fp scale ≥ r7 4(.091) 3.36** 4.6 8(.296) 10.26** 14.8
Ds scale ≥ r35 2(.045) 1.18 ---- 6(.222)  8.25** 11.1
FBS ≥ r34 7(.159) 5.17** 8.0 11(.407) 14.39** 20.4
Note. aCut-off scores in clinical settings from Caldwell for the 98th percentile 
(Greene, 2008); **p < .001.
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of the comparison of the observed likelihood with the one expected 
in the normative population (as in the test from the clinical 
population, we took the 98th percentile as the cut-off score, in this 
case from the manual for administration and scoring of the MMPI-2 
of Butcher et al., 1989) reveal that all the scales and indexes for 
measuring malingering report this to be significantly greater in both 
samples than in the normative population, oscillating –in the sample 
with chronic pain– between an over-invalidation of the protocols 
10.3 times higher than for the normative population in the Ds scale 
to 22.8 in FBS. The quantification of the overestimation of the 
invalidity of the protocol in patients with fibromyalgia (ORs) is even 
greater than among patients with chronic pain, with a range which 
oscillates between 24.1 times more than for the normative population 
in the Ds scale and F-K index to 37.1 times more in the F scale. Briefly, 
when forensic experts use these malingering indicators and decision 
criteria they are biased towards malingering. The study of the 
frequency of indicators per case does not allow us to establish a 
forensic decision criterion, as 6 malingering indicators were recorded 
both among those diagnosed both with chronic pain (n = 4) and with 
fibromyalgia (n = 6).
Continuing with the appraisal system of Arce et al. (2006, 2009), 
after the study of what they call negative criteria, that is, malingering 
indicators, comes the analysis of positive criteria, that is, of strategies 
for minimising false positives (authentic patients classified as 
malingerers). For our specific context, they propose the analysis of 
the MMPI-2 defensiveness scales and indexes. The cut-off points for 
suspected faking good are around the 95th percentile (stricter criteria 
are not recommendable because in the study assessment context, 
honest responses are expected and defensiveness is not suspected, 
and because of their contribution, to a greater extent than more 
conservative criteria, to the minimisation of false positives), which 
corresponds approximately with a likelihood, in the normative 
population, of cases of .05, which, in turn, is the criterion for 
statistical significance. By contrasting the expected likelihood (.05) 
with the observed one (see Table 6), we find a significantly higher 
prevalence of cases reported as typical of faking good than expected 
in the L, Wsd, MP, and Odecep scales in both the chronic pain and the 
fibromyalgia sample. For the case study, this means that fibromyalgia 
patients have a rate of cases classified as typical of defensiveness 
that is 4.4 times more than the expected likelihood for the Wsd scale, 
5.9 for Odecep, 7.4 for Mp, and 9.6 for L. Meanwhile, in the sample of 
patients with chronic pain the rate of cases classified by Wsd or 
Odecep as making self-favourable reports is 6.4 times greater than 
expected, a large effect size, while it is 10.5 times for Mp and 11.4 for 
L, large effect sizes. Additionally, 79.5% of patients with chronic pain 
were classified by at least 1 scale as defensive, 50% by 2 scales, 29.5% 
by 3 scales, and 13.6% by all 4 scales, whereas 59.3% of patients with 
fibromyalgia were classified as defensive by 1 scale, 44.4% by 2 
scales, 29.6% by 3 scales, and 3.7% by all 4 scales. Meanwhile, the K, 
S and Sd scales are totally insensitive to the labelling of the protocols 
in both samples, as characteristic of self-favourable reporting.
Discussion
Prior to discussing the results and their implications for forensic 
practice, it is necessary to warn of the limitations in their 
generalization and scope, which must be born in mind. First of all, 
although different steps were taken to ensure that patients with 
chronic organic pain and with fibromyalgia were genuine, it is not 
possible to totally guarantee that they were real patients suffering 
from chronic pain. Secondly, this thoroughness meant that the sizes 
of the experimental groups were reduced, which has an effect on the 
statistical estimations. Thirdly, the results cannot be generalised to 
other pathologies that are not chronic pain associated with 
fibromyalgia or with an organic etiology. Fourthly, MMPI-2 does not 
offer diagnoses, but rather diagnostic impressions, therefore it must 
necessarily be complemented with other evaluations, requiring a 
multi-method and, in this case, multidisciplinary approach (e.g., 
physical and medical tests); (Bianchini, Greve, & Glynn, 2005) for the 
differential diagnosis of malingering (Graham, 2006; Greene, 2011; 
Polusny & Arbisi, 2006; Pope, Butcher, & Seelen, 2006; Resnick, West, 
& Payne, 2008; Rogers et al., 2003). In accordance with these 
observations, we have drawn the following conclusions from our study:
a)  Even though the American Psychiatric Association (2002) points 
towards a lack of cooperation with the evaluation as a criterion for 
suspected malingering, there is no scientific evidence that this 
strategy is typical of malingerers in the forensic field (Baer & 
Miller, 2002; Rogers et al., 2003). Likewise, the results with the 
clinical samples in this study also reflect total collaboration. Either 
way, failure to collaborate is exceptional, both in clinical and 
normative samples (Butcher et al., 1989; Greene, 2011). From a 
purely cognitive perspective, a non-collaborative attitude in 
clinical assessments may be related to defensiveness (defence 
towards an unwanted assessment), a lack of cognitive skills to be 
able to complete the assessment, or spurious reasons. However, in 
the forensic evaluation, a motivational aspect must be applied 
such that if the person evaluated expects to obtain a benefit from 
the evaluation, s/he will collaborate, but if s/he may be adversely 
affected, this may not be so (e.g., involuntary commitment 
evaluations).
b)  The study of mean comparisons for the consistency measures 
showed that the responses from the populations with chronic 
Table 5
Classification Rate of Malingering Indicators with Normal Individual Cut-off Scores
Chronic pain Fibromyalgia
Indicator Cut-off scorea f(p) Z OR f(p) Z OR
F scale≥ ≥ r12 14(.318) 14.12** 15.9 20(.741) 26.80** 37.1
F-K index ≥ r4 11(.250) 10.90** 12.5 13(.481) 17.14** 24.1
Fb scale ≥ r9 10(.227)  9.81** 11.4 18(.667) 24.05** 33.4
Fp scale ≥ r4 17(.386) 17.35** 19.3 17(.630) 22.68** 31.5
Ds scale ≥ r24  9(.205)  8.77** 10.3 13(.481) 17.14** 24.1
FBS ≥ r22 20(.455) 20.62** 22.8 18(.667) 24.05** 33.4
Note. acut-off scores in normal individuals (Butcher et al., 1989); **p < .001.
Table 6
Cut-off Scores, Classification Rate and Contrast of the Prevalence of the 
Defensiveness Indexes
                Chronic pain Fibromyalgia
Indicator Cut-off 
score
 f(p) Z OR f(p) Z OR
L scale ≥ r7a 25(.568) 15.79** 11.4 13(.481) 10.29** 9.6
K scale ≥ r22a     0(0) ---- ----  1(.037) ---- ----
F-K index < r-21a     0(0) ---- ----    0(0) ---- ----
S scale ≥ r39a     0(0) ---- ----  1(.037) ---- ----
Wsd scale ≥ r18a 14(.318)  8.17**  6.4  6(.222)  4.10** 4.4
Esd scale ≥ r30.25b     0(0) ---- ----    0(0) ---- ----
Mp scale ≥ r13b 23(.523) 14.42** 10.5 10(.370)  7.64** 7.4
Odecep scale ≥ r19a 14(.318)  8.17**  6.4  8(.296)  5.87** 5.9
Note. aCut-off scores from Butcher et al. (1989); bcut-off scores from Baer and Miller 
(2002) are the mean scores of the meta-analysis for the non-coached under-
reporting group; Z for a proof value (H0) of .05; dashes for Z indicate that Z and the 
OR were not computed because the observed proportion of cases was ≤ .05 (H0); *p < 
.01, **p < .001.
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pain are more acquiescent but, just like the fibromyalgia group, 
with a mean within normality, that is, responses that are not 
biased towards true or false, and for which neither group follows 
randomised response patterns. However, the case study revealed 
that acquiescence is over-diagnosed (with the decision criterion ≥ 
13, in the sense of responses biased towards true) in populations 
with chronic pain and fibromyalgia. This over-diagnosis, as well as 
being significant, is a large effect size (OR > 4.25). Likewise, VRIN 
also over-diagnoses inconsistency linked to random responses in 
populations with chronic pain and fibromyalgia, with a moderate 
(2.47 < OR < 4.25) and large effect size (OR > 4.25), respectively. 
Equally, the |F-Fb| index over-diagnoses, with a large effect size, 
inconsistency (random responses) in the population of patients 
with fibromyalgia. These inconsistency indicators must be taken 
with caution in the forensic evaluation, as they are interpreted as 
signs of malingering due to their association with hypotheses 
such as a lack of cooperation (American Psychiatric Association, 
2000); but the over-diagnoses in these populations make it 
necessary to take into account other alternative hypotheses to 
malingering that are characteristic of clinical cases (e.g., clinically 
too confused, noncompliance) (Greene, 2008). The rate of false 
negatives linked to these inconsistency indicators must be added 
to this over-diagnosis. Hence, 14.9% of the randomly answered 
protocols lead to valid scores in VRIN (r < 13; Greene, 2011) in so 
far as there is no scientific evidence to support inconsistency in 
the responses of malingerers in the forensic field (Baer & Miller, 
2002; Rogers et al., 2003). Thus, the invalidation of a protocol due 
to inconsistency in these clinical populations is not advisable 
since, in addition to the fact that it is not characteristic of 
malingerers (it would, in any case, be a positive criterion, that is, 
not malingering), it has a significantly higher likelihood of being 
found in clinical cases, therefore other alternative hypotheses 
must be studied.
c)  The study of the validity of protocols revealed that in 6 of the 
malingering measuring scales and indexes, 3 original ones (F, Fb, 
and F-K) and 3 additional ones (Fp, Ds, and FBS), the patients with 
fibromyalgia reached higher means than the control group. 
Moreover, the Esd scale, indicative of defensiveness, also 
differentiated between both groups, with fibromyalgia patients 
obtaining lower means. Meanwhile, the group of patients with 
chronic pain reached means greater than the control group in the 
additional malingering measuring scales: Ds and FBS. In short, the 
6 malingering indicators are biased against real fibromyalgia 
patients by 2 (none of the original ones) of the chronic pain ones. 
As a result, psychologists are biased in their judgments by these 
scales and indexes towards malingering, especially in patients 
with fibromyalgia. Yet, these results have no implications for 
clinical or forensic practice with N = 1 designs.
d)  The case study, in a clinical setting, revealed that all the malingering 
scales and indexes would wrongly over-diagnose real cases of 
fibromyalgia as malingerers (invalid) with large effect sizes (ORs > 
4.25), whereas the Fp and FBS would do so with the cases of 
chronic pain, also with large effect sizes. For the purposes of daily 
clinical practice, these results have totally different implications 
for fibromyalgia populations and chronic pain populations as in 
the original malingering scales and indexes –which are the ones 
normally used by clinical psychologists– they do not over-diagnose 
in clinical cases of chronic pain but they do in cases of fibromyalgia. 
Since up to 5 malingering indicators were recorded in cases in 
both populations, in order to ensure a subject is faking bad 
without the commission of false positives, more than 5 indicators 
(gold standard) of malingering (negative criteria, that is, that 
invalidate the protocol, in the model of Arce et al., 2006, 2009) 
will have to be verified in both populations.
e)  The case study for the forensic setting (that is, contrasted with the 
normative population) warns that the 6 evaluation scales and 
indexes for malingering overestimate this, with very large effect 
sizes (ORs from 10.3 to 37.1, that is, from 1.29 to 2 standard 
deviates) in both populations. Briefly, forensic experts, when using 
these malingering indicators and decision criteria, are informed in 
a biased way. Since these scales and indexes are biased towards 
malingering and in the forensic evaluation a differential diagnosis 
of malingering is required (American Psychiatric Association, 
2000), the malingering scales and indexes lead forensic 
psychologists to make mistakes in their classification of true 
fibromyalgia and chronic pain patients as malingerers (false 
positives). The results do not allow us to establish a forensic gold 
standard that will enable the identification of true positives 
without the commission of false positives, as we have recorded 
real cases classified as malingerers in both populations for all the 
malingering measuring scales and indexes.
f)  The overestimation of invalidity of the response protocols, both 
with the standards in a clinical setting and in the normative 
population, suggests that other alternative hypotheses to 
malingering must be studied, such as the presence of a severe 
psychopathology (e.g., Graham, 2006; Greene, 2011). The solutions 
proposed for the (re)classification as true negatives of the genuine 
cases classified as malingerers by the validity scales and indexes, 
are the clinical decision models for establishing malingering 
(Bianchini et al., 2005; Cunnien, 1997; Resnick et al., 2008) and the 
presence of positive criteria, that is, the presence of criteria that 
are not under the subject’s voluntary control, or of indicators that 
are not found in cases of malingering (Arce et al., 2006, 2009). 
With the application of the MMPI-2, there is only room for the 
search for criteria that are not found in faking bad, which are the 
indicators of defensiveness. The base rate of defensiveness in 
evaluation contexts in which it is the hypothesis to be suspected 
(e.g., custody litigations, job applications) has been estimated at 
25-30% (Baer & Miller, 2002; Fariña, Arce, & Sotelo, 2010), whereas 
among malingerers in the forensic evaluation of psychological 
damage, compensation for damages or disability (characteristic 
fields of forensic evaluation of chronic pain and fibromyalgia), this 
rate turned out to be zero (Arce et al., 2006, 2009). This is because 
psychopathology is inversely related to defensiveness (Greene, 
2008) and because malingerers do not bias their responses towards 
social desirability or hide symptoms, but rather quite the opposite, 
they subtract symptoms or attribute positive characteristics that 
they do not have (Arce et al., 2006, 2009, Fariña et al., 2010). The 
results only support differences between means in the Esd scale, 
which is lower for fibromyalgia patients than in the control group, 
that is, biased against defensiveness. However, in the classification 
of defensiveness, the L, Wsd, Mp, and Odecep scales significantly 
classified –with large (OR > 4.25) effect sizes– the protocols of 
fibromyalgia and chronic pain patients above the normative 
population. These scales share the impression management 
measurement (Paulhus, 1991; Strong, Greene, Hope, Johnston, & 
Olesen, 1999), which is characterised because the people evaluated 
consciously create a favourable impression of themselves in the 
evaluator. Cognitively, impression management is contrary to 
malingering strategies (for the strategies followed by malingerers, 
see Rogers, 2008), thereby a malingerer is not expected to 
consciously handle the impression to be caused so that it will be 
positive. The presence of an indicator of conscious self-favourable 
reporting enables us to (re)classify 79.5% of the protocols of 
patients with chronic pain and 44.4% of those with fibromyalgia as 
true negatives (that is, genuine cases). On the other hand, the Esd, 
K and S scales are utterly insensitive to the classification of 
fibromyalgia and chronic pain patients as making self-favourable 
reports. These are related to self-deceptive positivity (Paulhus, 
1991; Strong et al., 1999), an unconscious distortion of the degree 
of adjustment, mental health, optimism and self-esteem, which 
detection would indicate that it is a true positive.
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